AB Science touts positive Phase II Covid-19 data for masitinib
AB Science aimed to enrol 200 patients in the trial, but the study stopped enrolling after 95 patients due to recruitment challenges.
Covid-19
NIH announces start of subject enrolment for nasal Covid-19 vaccine trial
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Health Canada grants approval to Entos for Covid-19 vaccine booster trial
AstraZeneca’s Phase III Covid-19 antibody trial meets primary endpoints
Allucent receives grant for decentralised Covid-19 vaccine trial
Moderna’s Phase III Covid-19 vaccine trial meets primary endpoints
